Heart failure drug trial ends early – only 4 patients enrolled
Disease control
Terminated
This was a very early (Phase 1) study testing a drug called HS135 in obese patients who have both pulmonary hypertension and a type of heart failure called HFpEF. The trial was terminated after enrolling only 4 people, so we have no useful information on whether HS135 is safe or …
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC